Patient Guide: A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 19 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05516914
Status: 🟢 Enrolling Now
Condition: Malignant Tumors
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 19 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Hefei, Anhui
  • • Fuzhou, Fujian
  • • Guangzhou, Guangdong
  • • And 16 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors - Join Clinical Trial NCTNCT05516914

How to Join This Clinical Trial - NCTNCT05516914

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Malignant Tumors. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Malignant Tumors. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Malignant Tumors
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05516914 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 19 locations. Find a study site near you:

Clinical Research Site

Hefei, Anhui 230031 - China

Status: RECRUITING

Clinical Research Site

Fuzhou, Fujian 350001 - China

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510060 - China

Status: RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510120 - China

Status: RECRUITING

Clinical Research Site

Huizhou, Guangdong 516000 - China

Status: RECRUITING

Clinical Research Site

Jiangmen, Guangdong 440700 - China

Status: RECRUITING

Clinical Research Site

Maoming, Guangdong 525000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Zhanjiang, Guangdong 524000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Nanning, Guangxi 530000 - China

Status: RECRUITING

Clinical Research Site

Nanning, Guangxi 530021 - China

Status: RECRUITING

And 9 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Malignant Tumors:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation